John Rotrosen

Dr. Rotrosen’s research has focused on addictive disorders, attention- deficit/hyperactivity disorder, and schizophrenia and movement disorders, addressing pathophysiology, pharmacological and behavioral intervention, and the translation of research to community settings. His research group has contributed to the development of many of the atypical antipsychotic agents; and of new medications; novel forms of medication delivery; and behavioral therapies for opiate, cocaine, alcohol, and nicotine dependence. He was PI of the VA NY Harbor Healthcare System–based National Institute on Drug Abuse (NIDA)/VA Medications Development Research Unit from 1995 to 2001 and of the New York Node of the NIDA Clinical Trials Network, now the Greater New York Node, along with co-PI Dr. Ned Nunes. Dr. Rotrosen has recently served on the NIDA National Advisory Council on Drug Abuse, and previously served on the NIMH National Advisory Mental Health Council. Current work in addictive disorders includes studies in clinical genetics, neuroimaging, medication and behavioral therapies development, implementation in mainstream healthcare settings, services and healthcare disparities, and practice improvement.